Incidence and clinical outcomes of diabetes mellitus in HIV-infected adults in Thailand: a retrospective cohort study

Paengsai, Ninutcha; Jourdain, Gonzague; Chaiwarith, Romanee; Tantraworasin, Apichat; Bowonwatanuwong, Chureeratana; Bhakeecheep, Sorakij; Cressey, Tim Roy; Mary, Jean Yves; Salvadori, Nicolas; Kosachunhanun, Natapong

doi:10.1186/s12889-018-5967-7

Table 3 Prevalence of diabetes related complications among HIV-infected adults with diabetes during last year of follow-up (Fiscal Year 2014)

From: Incidence and clinical outcomes of diabetes mellitus in HIV-infected adults in Thailand: a retrospective cohort study

Type of complications	Category	Sub category	Number of patients with complications	Total	P-value^a	Annual prevalence (%)	95% CI
MICROVASCULAR OR MACROVASCULAR			1313	7905		16.61	15.72–17.53
	Sex				0.144
		Female	596	3444		17.31	15.94–18.75
		Male	717	4461		16.07	14.92–17.29
	Age in years				< 0.001
		18–34	81	770		10.52	8.35–13.07
		35–44	321	2901		11.07	9.89–12.34
		45–59	658	3543		18.57	17.18–20.05
		≥60	253	691		36.61	32.24–41.41
MICROVASCULAR			911	7905		11.52	10.79–12.30
Ophthalmic			246	7905		3.11	2.74–3.53
	Sex				0.122
		Female	119	3444		3.46	2.86–4.13
		Male	127	4461		2.84	2.37–3.39
	Age in years				0.004
		18–34	25	770		3.25	2.10–4.79
		35–44	71	2901		2.45	1.91–3.09
		45–59	115	3543		3.25	2.68–3.90
		≥60	35	691		5.07	3.53–7.04
Diabetic retinopathy			49	7905		0.62	0.46–0.82
	Sex				0.443
		Female	24	3444		0.7	0.45–1.04
		Male	25	4461		0.56	0.36–0.83
	Age in years				0.072
		18–34	2	770		0.26	0.03–0.94
		35–44	13	2901		0.45	0.24–0.77
		45–59	26	3543		0.73	0.48–1.08
		≥60	8	691		1.16	0.50–2.28
Renal			615	7905		7.78	7.18–8.42
	Sex				0.174
		Female	284	3444		8.25	7.31–9.26
		Male	331	4461		7.42	6.64–8.26
	Age in years				< 0.001
		18–34	24	770		3.12	2.00–4.64
		35–44	149	2901		5.14	4.34–6.03
		45–59	305	3543		8.61	7.67–9.63
		≥60	137	691		19.83	16.65–23.44
Neurological			163	7905		2.06	1.76–2.40
	Sex				< 0.001
		Female	101	3444		2.93	2.39–356
		Male	62	4461		1.39	1.07–1.78
	Age in years				< 0.001
		18–34	4	770		0.52	0.14–1.33
		35–44	32	2901		1.1	0.75–1.56
		45–59	86	3543		2.43	1.94–3.00
		≥60	41	691		5.93	4.26–8.05
MACROVASCULAR			545	7905		6.89	6.33–7.50
Ischaemic heart diseases			243	7905		3.07	2.70–3.49
	Sex				0.681
		Female	109	3444		3.16	2.60–3.82
		Male	134	4461		3	2.52–3.56
	Age in years				< 0.001
		18–34	14	770		1.82	0.99–3.05
		35–44	45	2901		1.55	1.13–2.08
		45–59	116	3543		3.27	2.71–3.93
		≥60	68	691		9.84	7.64–12.48
Cerebrovascular disease			212	7905		2.68	2.33–3.07
	Sex				0.002
		Female	70	3444		2.03	1.58–2.57
		Male	142	4461		3.18	2.68–3.75
	Age in years				< 0.001
		18–34	10	770		1.3	0.62–2.39
		35–44	45	2901		1.55	1.13–2.08
		45–59	109	3543		3.08	2.53–3.71
		≥60	48	691		6.95	5.12–9.21
Peripheral circulatory			123	7905		1.56	1.29–1.86
	Sex				0.174
		Female	61	3444		1.77	1.35–2.28
		Male	62	4461		1.39	1.07–1.78
	Age in years				< 0.001
		18–34	10	770		1.3	0.62–2.39
		35–44	24	2901		0.83	0.53–1.23
		45–59	70	3543		1.98	1.54–2.50
		≥60	19	691		2.75	1.66–4.29
Amputation			25	7905		0.32	0.20–0.47
	Sex				0.719
		Female	10	3444		0.29	0.14–0.53
		Male	15	4461		0.34	0.19–0.55
	Age in years				0.214
		18–34	4	770		0.52	0.14–1.33
		35–44	5	2901		0.17	0.06–0.40
		45–59	12	3543		0.34	0.18–0.59
		≥60	4	691		0.58	0.16–1.48

^aFisher’s exact test

Back to article page

ISSN: 1471-2458

Contact us

Submission enquiries: bmcpublichealth@biomedcentral.com
General enquiries: ORSupport@springernature.com

BMC Public Health

Contact us